Suchergebnisse - "Fisk, John D"

PubPharm (13)

1

Well-being and flourishing mental health in adults with inflammatory bowel disease, multiple sclerosis and rheumatoid arthritis in Manitoba, Canada : a cross-sectional study

enthalten in: BMJ open | 2023

von Almweisheer, S. | Bernstein, C. | Graff, L. | +16

2

Etiology, effects and management of comorbidities in multiple sclerosis : recent advances

enthalten in: Frontiers in immunology | 2023

von Marrie, R. | Fisk, J. | Fitzgerald, K. | +5

3

Sex differences evident in elevated anxiety symptoms in multiple sclerosis, inflammatory bowel disease, and rheumatoid arthritis

enthalten in: Frontiers in psychiatry | 2023

von Joyees, J. | Marrie, R. | Bernstein, C. | +24

4

Differences in resting state functional connectivity relative to multiple sclerosis and impaired information processing speed

enthalten in: Frontiers in neurology | 2023

von Carter, S. | Patel, R. | Fisk, J. | +10

5

Disease-modifying drugs for multiple sclerosis and subsequent health service use

enthalten in: Multiple sclerosis (Houndmills, Basingstoke, England) | 2022

von Ng, H. | Zhu, F. | Kingwell, E. | +8

CommentIn: Mult Scler. 2022 Apr;28(4):499-501. - PMID 35296176

6

The comorbidity and cognition in multiple sclerosis (CCOMS) neuroimaging protocol : Study rationale, MRI acquisition, and minimal image processing pipelines

enthalten in: Frontiers in neuroimaging | 2022

von Uddin, M. | Figley, T. | Kornelsen, J. | +15

7

Effects of Vascular Comorbidity on Cognition in Multiple Sclerosis Are Partially Mediated by Changes in Brain Structure

enthalten in: Frontiers in neurology | 2022

von Marrie, R. | Patel, R. | Figley, C. | +10

8

Use of Benzodiazepines and Z-Drugs in Multiple Sclerosis

enthalten in: Frontiers in neurology | 2022

von Marrie, R. | Fisk, J. | Walld, R. | +11

9

Disease-Modifying Drug Uptake and Health Service Use in the Ageing MS Population

enthalten in: Frontiers in immunology | 2021

von Ng, H. | Graf, J. | Zhu, F. | +10

10

Characteristics of a population-based multiple sclerosis cohort treated with disease-modifying drugs in a universal healthcare setting

enthalten in: Expert review of neurotherapeutics | 2021

von Ng, H. | Zhu, F. | Kingwell, E. | +8